Murli Krishna Pharma Private Ltd. is a 20-year-old Indian organization that provides a range of innovative solutions to optimize the delivery of pharmaceutical preparations.
We manufacture Pre-Finished Formulation Intermediates and Finished Dosage forms in our plant that is approved by the European Union, WHO, GCC and Jordanian FDA. Our PFI product range is in the form of Pellets & Micro Pellets.

Alphabetical list of our PFI products

Category
Showing 21 – 40 of 44 results Showing all 44 results Showing the single result No results found
Filters Sort results
Reset Apply
Product Name
Percentage
Mesh Size
Release Type
Target Formulations
22%
,
44%
14#18
,
16#20
,
20#24
Immediate Release
Capsules
12.5%
,
8.5%
12#16
,
14#18
,
16#20
,
18#20
,
20#22
,
22#24
,
24#30
,
30#40
,
40#60
Delayed Release
Capsules
|
Premix
|
Tablets
-
-
-
-
76%
,
80%
-
Extended Release
Capsules
-
-
-
-
60%
,
70%
,
90%
,
96.38%
14#20
,
16#80
Extended Release
Capsules
|
Suppositories
|
Tablets
50%
-
Immediate Release
Capsules
|
Suspension
|
Tablets
22%
-
-
-
10%
,
20%
,
22.5%
,
22%
,
30%
,
8.5%
12#14
,
12#16
,
14#18
,
16# 20
,
18#20
,
20#24
,
24#30
,
30#40
,
40#60
Delayed Release
Capsules
|
Tablets
50%
14#20
,
18#30
Immediate Release
Capsules
0.5%, 1%, 5%
100 micron used in injection
-
Injectables
10000 IU
,
25000 IU
,
36000IU
,
40000IU
,
70% (Bovine & Porcine)
-
Delayed Release
Capsules
15%
14#18
,
16#20
Delayed Release
Capsules
|
DC Mix
5%
-
-
Topical Cream
-
-
Delayed Release
Capsules
10%
,
7.5%
,
8.5%
-
Delayed Release
Capsules
0.3%, 0.6%, 1.2%
16# 20
,
35#70
Immediate Release
Capsules
|
Tablets
0.5%
,
1.0%
,
5.0%
16# 20
,
35#50
,
50#70
Immediate Release
Capsules
20%
-
-
Injectables
.13%
,
.16%
,
.20%
,
0.125%
-
Extended Release
Capsules
123